Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think that is correct , by reading that . maybe go to the IRS website to confirm
According to Fox Business, cash dividends do not lower the cost basis of an investment. A stock dividend, however, does adjust cost basis, as does a “return of capital”. As far as the Internal Revenue Service is concerned, it’s as if you received the dividends in cash and sent money back to buy more shares. Your cost basis increases by the amount of money used to buy the stock1.
That would be nice , but is their share structure able to handle ?
I would be good with that , Jim would love to see a 5 million dividend , now we just need Dog to post a few videos and the good ole days would be back
Its is nice the board is thinking positive compared to the A.M. post. We all would like a little more info on this investment , but many have been here for years and nothing has changed on how Enzolytics has communicated in the past year. Let them work their magic behind the scenes and by X-Mas we all will be happy. Africa news is what will really be the start of the shift. Meanwhile enjoy the summer buy more if you want just hold with diamond hands til the fall. GLTA
How is I Glow not on ignore by everyone?
VIRO is also in the process of completing the application with the United Stated Federal Drug Administration (the “FDA”) for two new additional nutraceutical products developed by Dr. Lachezar Ivanov. The products will be for detoxification of the brain and detoxification of the liver. The liver detox is currently registered and being sold in Bulgaria. The brain detox initial registration application will be filed with the FDA and subject to its approval.
Harry Zhabilov, CSO of VIRO and ENZC stated, “I am proud of the success and progress that the VIRO Team has brought to ENZC through the two products currently being manufactured and developed in Bulgaria. With the expansion of the nutraceutical product line and our first administration of the ITV-1 immunotherapy in Africa, we believe that in the last half of 2023, great strides will be made toward fulfilling my vision for the ITV-1 family of products. The potential of additional funding through the previously discussed SPAC transaction will increase the opportunities for further product development, all of which will be covered by our Multiple Sclerosis patent application currently pending.”
Enzolytics filed for the Multiple Sclerosis patent application currently pending.
Again IMO Enzolytics has done the heavy lifting over the last three years , they now will manage the patents and the work will be carried on by the doctors. Remember they have something like 450 million Enzolytics shares between them . Does anyone really think they are going to let Enzolytics fall to the wayside. IMO GLTA
Capt all I can say is everything has been filed under Enzolytics not the two subs, like I stated if anyone can post showing that the two subs have patent pending filings please post. They only thing I have found is the immune items would go to Sage. The major patents filings have all been Enzolytics nothing referencing the two subs are on filings applications that I have been able to find. GLTA
An extensive patent portfolio will provide a return on investment through partnering or licensing technology covered by multiple international patents."
IMO this is what Enzolytics will have the patents. Patents were filed under Enzolytics not the two subsidiaries from what I am finding. If true then Saga deal would be for the two companies to lease the rights from Enzolytics. If someone can find anything stating the two companies being sold by Enzolytics has filed for any patents please post, I have not been able to find any applications for the two subsidiaries , only Enzolytics. Below are a few of the post that clearly states Enzolytics patent pending filings. It appears that SAGA will put the companies together and carry on the work while Enzolytics manages partnering or licensing technology and royalties.IMO GLTA
https://finance.yahoo.com/news/enzolytics-announces-international-patent-office-103000840.html
https://www.nasdaq.com/press-release/enzolytics-inc.-files-provisional-patent-for-treatment-of-multiple-sclerosis-2020-12#:~:text=PLANO%2C%20TX%20%2F%20ACCESSWIRE%20%2F%20December%2010%2C%202020,CORD%20%28SCNP%29%20IMMUNE%20FACTOR%2C%20S%20er.%20No.%2062%2F123341.
https://www.accesswire.com/694640/Enzolytics-Highlights-Its-Comprehensive-PCT-Patent-Applications-Covering-Discovered-Conserved-Target-Epitopes-on-the-SARS-CoV-2-and-HIV-Viruses
https://enzolytics.com/company-news/
https://enzolytics.com/enzolytics-inc-intellectual-property/
https://www.nasdaq.com/press-release/enzolytics-announces-its-new-technology-for-entry-into-the-in-vitro-diagnostics
So on news of SAGA and a buy of 250m ENZC went to .13 , now a 450m offer do we see .18/.20 now that would be nice to see. GLTA
BM what I have been watching is when the patents were filed and we are coming up on most of them at the 2 year mark, so information should start being released that they have been approved or not. The other thing we should be hearing about is the animal side. This copy paste below is from Jan 2023. GLTA
Enzolytics announced its ongoing efforts to develop fully feline Monoclonal Antibodies. Enzolytics utilizes its proprietary Artificial Intelligence (AI) platform to produce species-specific monoclonal antibodies. Abveris, a Boston-based biotechnology company providing contract research services to biopharmaceutical industry partners, will use feline donor PBMC samples and peptide screening tools provided by Enzolytics to perform a B cell screening-based Ab discovery project to identify antigen-binding antibodies for further characterization by Enzolytics. The resulting fully feline monoclonal antibodies are expected to be used in scientific applications, including ELISA, Western Blot, immunohistochemistry, and immunocytochemistry for diagnostics.
After reading the link proved earlier about insurance it depends on the location and ENZC knew where they would be testing, so it is kinda like they dropped the ball on being prepared to follow thru on time. GLTA
Only thing new was the application for GNC , the rest was copy and paste. GLTA
I understand what you are saying ,
You get a quote on car insurance when looking for a partical car before buying it ? and what it will take to put the policy in effect.
It is more like they know what they have , but don't know what actually it takes at times to make it happen. Not saying I could do better in anyway shape or form. If we can research and find out as you did what EU requires you would think they could to. GLTA
I
Thanks for this, the one question that should be asked is why didn't Enzolytics prepare for the insurance that would be needed. They have been talking about Africa testing since 2022 , so why the month they say it will start the trials do we get an update that insurance is needed and will take approx 2 months this is why the delay of start. GLTA
https://www.morningstar.com/news/accesswire/759257msn/enzolytics-offers-update-on-virogentics-and-sale-transaction-clinical-trials-progress-on-european-medicine-agency-ema-permitting-and-arican-itv-1-project
July August
A new comprehensive report prepared by the Bulgarian Academy of Sciences - Institute of Inorganic Chemistry and Phytotherapy was released last week for ITV-1, using two Bradford methods and spectrophotometric studies. The concentration of proteins in the final product was found to be in sufficient quantity to be able to bind and be active. The molecular masses of the peptides were determined. The amino acid sequence of 51 peptides in the ITV-1 samples have been identified. These and many other important pieces of information were obtained from this report along with schematics and diagrams. VIRO has engaged the German company Cooperative Clinical Research and Development (Korporativ Klinik Drug Research and Development) to prepare the Pharmacokinetic study on the porcine pepsin. This study is scheduled to begin on June 25, 2023. The production report and research dossier required for phase 3 clinical trials under the EMA guidelines are currently being prepared.
The final protocol for the administration of the ITV-1 immunotherapy treatment under the supervision of Neuro Pharma Ltd - Rwanda, to be dispensed to volunteers under a fast-track protocol at HEAL Africa Hospitals, GOMA, PRC and Panzi Hospital, Bukavu, DRC, is expected to be completed this week. The impact of the treatment on the HIV/AIDS virus present in the volunteers will be reported after the 17-week cycle is complete. The next step for VIRO is to acquire and fund the insurance premiums for the volunteers. VIRO expects ITV-1 to be dispensed under the trial in late July / early August 2023.
101 its being held down so some can make money , how many times have we heard this . HAHAHAHA Just joking
Correct , Funny how some forget that they stated first week of June then we heard nothing the first two weeks and then we got insurance is needed and it will be July August now , putting results basically in Nov now.
No problem Here you go , at first they said they would deliver in May so most took it as soon as it arrived it would be started then we were told 1st week in June .
https://finance.yahoo.com/news/virogentics-inc-receives-report-bulgarian-121000337.html
Hopefully we see something different , but I see Oct as the earliest we really get anything of substance. Africa hasn't started so we know nothing from that will come. So we can't argue about anything that hasn't even started. So what we have is filings which is and has been controlled by CC. EU won't happen until Africa has shown results, Regengenron said late 2023 , and oh yeah 4 more extentions from SAGA. So all we have is trade at the levels that we are in Buy , Hold , Sell and thank whoever is in control has decided to hold in the .05 range and not the so called .02 or lower range. All have a great weekend , see you on Monday GLTA
Not that anyone has found , Regeneron and their new deal maybe ENZC it may noy . no one knows as of now. Timelines all match up but anyone guess. They have not gone full reporting for a reason , what that is noone but ENZC knows why. GLTA
Dont you always point out that they haven't come thru yet on what they say so you cash in on the hype and the drawbacks . Give all of us a break from I am making bank ect.. We all have seen we cant get orders filled but you and the program can buy low sell high everytime. GLTA
I am not saying it isnt, but if you want to say they said. They also said it would be started in May . not here to argue with anyone, they have said alot and it has not materialized at this point.
Dyno , looking up patent coverage , if they change or add something to the mix they can patent the new version since the patent has expired and is altered it is not the same so maybe that is what they are doing . just guessing as everyone else is . GLTA
BM dont take this the wrong way , but nothing is in Africa yet , so noone really knows what they have or will be testing in Africa and the EU. Time is the only thing that will tell us what is actually happening with ENZC. GLTA
Your right , that is why I gave the link so it could be looked at. That is why I have a Sept to OCT for any real PR to come out . All just guessing at this point , but when it happens I think it will be very good for SP GLTA
The date by which Sagaliam has to complete its business combination has been extended from April 23, 2023, to May 23, 2023. The Extension is the fifth of ten one-month extensions permitted under Sagaliam's governing documents and provides the Company with additional time to complete its business combination.
I would say Sept 23 and then a few days afterward to finish deal completely
https://www.biospace.com/article/releases/enzolytics-inc-continues-progress-with-business-combination-biogenysis-announces-team-and-plans-for-success/
A few good reads we could be looking at the insurance thing wrong it could be just health insurance one is offered .( the fact of participating in a clinical trial may constitute for the patient the only opportunity to have access to healthcare.) from one of the reads GLTA
https://www.news-medical.net/whitepaper/20210722/How-Africa-could-become-a-new-center-for-clinical-trials.aspx
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(22)00243-1/fulltext
https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1347&context=jhclp
https://pubmed.ncbi.nlm.nih.gov/32711568/
https://www.appliedclinicaltrialsonline.com/view/eu-ethics-and-africa-trials
Dont worry I am not going anywhere bought and held this lon what is a few more months. GLTA
This range has been the low lately so shouldn't you be buying ? 50k worth would be aprox 990k shares that would move the volume
What do you know I just got 1 of 3 orders filled for 20k shares at .0510 that have been open for two weeks. GLTA
Something went south in Africa for sure timeline was start in May, had been working with officials, already there setting up and then oh we need insurance and the start is July or August now. That is why I think it was asked for by the officials because they sensed that ENZC needs this trial to happen, so they had the bargaining chip and not ENZC. Now the hard part is getting exactly what to be covered by insurance. The people involved already are infected so insurance can't cover that part of the issue , so is it going to cover any issues arising from ENZC that brings on a different issue other than what is currently present. We know from other studies and test that it has proven safe. Who knows but ENZC what is going on, we are all just trying to put piece of the puzzle together at this point and everytime we are almost think we have the puzzle figured out we get a 1000 more pieces add to the mix.
Jim what is your take and are you still on that 15 month plan or will you be holding a bit longer?
GLTA
I hear ya , I really dont see anything being released as major news or deals until late Sept Oct maybe even Nov. , They haven't started in Africa according to their own PR due to insurance issues. That is a new one on me, haven't seen a trial needing insurance usually just the opposite you sign waivers over issues occuring from it. Not saying it hasnt ever been asked for or issued. Africa could have asked for it since they knew ENZC needs to do a trial, ENZC could have offered it, but you would think they would have already set it up ahead of time and had it ready to go as a bargaining chip. That kind of makes you think it was Africa officials that asked for it. Either way a few more months is not a big thing if you are long and have confidence in the company. Hoping I am dead wrong about major news timeline and it is dropped earlier than my thinking.The patent timeline puts us all most in August, Regeneron stated late in the year 3rd Qrt starting trials, and Africa results at the midway mark is at its best Sept, that is why I have my own timeline in mind. GLTA
Come on now MP you know a few just made beer money on the Low to High just now Just a little Friday sarcasm. GLTA
Wishing you a Speedy recovery . GLTA
I for one and many others have had orders go unfilled and alot less than a million share you are buying. So something is going on or are you just that lucky all the time? show the magic and pull off a 750k to 1 million buy today
I think this is what we are thinking we read, go to claims that was where I was recalling the 38 steps ect.. GLTA
DRHUMI
Re: None
Thursday, March 23, 2023 12:25:54 PM
Post#
172178
of 179649
The written opinion is brutal on the patent application. I have no idea what "opinion" means concerning the possible issuance of the patent... Is it literally an opinion by a bunch of geeks that can't influence the decision?
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2023043880&_cid=P21-LFL63P-93947-1
BonnieMac
Re: DRHUMI post# 172189
Thursday, March 23, 2023 1:20:42 PM
Post#
172191
of 179649
You have to go back to $ENZC's PR's in the past to find the Announcement about its original WIPO Application. You can find it on our Co. Website. The PR stated that ENZC had been given preliminary Approval for its HIV Patent as being novel and inventive. The waiting/review period for Approval is 18 months, which is up now & WIPO granted Approval for ENZC's Patent Application today.
BonnieMac
Re: DRHUMI post# 172178
Thursday, March 23, 2023 12:55:28 PM
Post#
172186
of 179649
WIPO website stated today, Mar. 23, 2023:
"Abstract
(EN) Described are novel HIV-binding peptides and methods of using them for treating or preventing HIV infection and/or the development of AIDS."
The 18-month waiting period is up now, so approval that $ENZCs patent is "novel" has just been given.
See Godfather's Tweet posted about 1 hr ago today, Mar. 23, 2023:
This is fabulous News!